Clinical Trial

Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores

Name: Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores — clinical trial record (NCT07152756)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A prospective, single-center, observational study to compare the risk of gastric retention and endoscopic mucosal visibility between the exposure group (one-week discontinuation of semaglutide before EGD) and non-exposure group (no semaglutide use before EGD)

Trial Details

NCT Number	NCT07152756
Lead Sponsor	Fudan University
Conditions	Gastric Retention
Enrollment	418 participants
Start Date	2025-09-15
Primary Completion	2028-09-15 (estimated)
Study Completion	2028-09-15 (estimated)
Updated on ClinicalTrials.gov	2025-09-03